Pfizer Gets CDSCO Panel Nod To Conduct Phase III CT of Rimegepant Dr. Divya Colin9 Nov 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Pfizer has received the go-ahead from the Subject Expert Committee (SEC), which is functional under the Central Drug...
Medical Bulletin 20/ September/ 2024 Dr. Bhumika Maikhuri20 Sept 2024 3:00 PM ISTHere are the top medical news for the day:Clinical Trial Finds Two common surgical approaches Equally Effective for Managing Trachomatous Trichiasis...
Systematic Review Finds Triptans Outperforms Newer Expensive Migraine Drugs Dr. Bhumika Maikhuri20 Sept 2024 8:15 AM ISTSome triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published...
Triptans more effective than newer, more expensive migraine drugs: BMJ Dr. Kamal Kant Kohli19 Sept 2024 5:00 AM ISTSome triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published...
Conduct Randomized Control Phase III CT in Indian Population: CDSCO Panel Tells Pfizer on Rimegepant Dr. Divya Colin15 March 2024 6:00 PM ISTNew Delhi: Rejecting the proposal for local Phase III clinical trial waivers, the Subject Expert Committee (SEC) functional under the Central Drug...
Pfizer, Biohaven get European Commission marketing nod for migraine drug Vydura Ruchika Sharma28 April 2022 12:00 PM ISTVYDURA is taken orally as needed, up to once daily, to stop migraine attacks or taken every other day to help prevent migraine attacks.
Newer pharmacologic agents not as good as triptans for treating migraines; JAMA Dr Kartikeya Kohli13 Oct 2021 9:22 PM ISTNew therapeutic classes of migraine-specific treatment have been developed, including 5-hydroxytryptamine1F receptor agonists (lasmiditan) and...
Rimegepant and Zavegepant Show Promising Results for Treatment of Migraine Josepha James10 Jun 2021 9:00 AM ISTNurtec ODT (rimegepant) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a quick-dissolve ODT...
Rimegepant effective for migraine prevention: Lancet Medha Baranwal24 Dec 2020 6:45 PM ISTUSA: Rimegepant, when taken every other day, can help in the prevention of migraine, shows a recent phase 2/3 trial. The findings of the study,...
FDA approves fast acting Rimegepant for treating acute migraine in adults Dr. Kamal Kant Kohli28 Feb 2020 9:02 AM ISTFDA Approves fast acting Rimegepant for acute treatment of Migraine in adultsHAVEN, Conn. -- The U.S. Food and Drug Administration (FDA) has approved...
